PR is from 2020. “Taipei, Taiwan (March 20, 2
Post# of 148192
(Total Views: 511)
Posted On: 03/04/2021 7:34:15 PM
Re: Goosebumps #80762
PR is from 2020.
“Taipei, Taiwan (March 20, 2020) In the past week Amarex worked with client CytoDyn to prepare, submit and achieve FDA approval for an EUA for CytoDyn’s leronlimab, a monoclonal antibody product, as a potential treatment for coronavirus disease 2019 (COVID-19). Amarex CEO, Dr. Kazem Kazempour, explained, “Cytodyn’s product has the potential to control the body’s hyper-immune response to coronavirus infection which contributes to life threatening side-effects of the disease.”
“Taipei, Taiwan (March 20, 2020) In the past week Amarex worked with client CytoDyn to prepare, submit and achieve FDA approval for an EUA for CytoDyn’s leronlimab, a monoclonal antibody product, as a potential treatment for coronavirus disease 2019 (COVID-19). Amarex CEO, Dr. Kazem Kazempour, explained, “Cytodyn’s product has the potential to control the body’s hyper-immune response to coronavirus infection which contributes to life threatening side-effects of the disease.”
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼